Based on our previous findings of the induced malignancy of triple negative BCC by SARS-CoV-2 membrane protein (M-protein) (6), we expanded the study to examined the effects of M-protein on EV derived from triple negative BCC. The gene discussed is MYOM2; the disease is skin basal cell carcinoma.